27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
Many companies will consider selling their offshore captives/GICs in the wake of COVID-19, especiall...
Read More >
In late 2018, in Sulyma v. Intel Corporation Investment Policy Committee, the Ninth Circuit Court of...
Read More >
First, the good news: The Equal Employment Opportunity Commission (EEOC) has provided notice that it...
Read More >
Webinar Agenda –Public Agency - 1.Health and Welfare Plan Updates: •Affordable Care Act Updates ...
Read More >
Seyfarth Synopsis: The U.S. Department of Labor announced its final rule updating and revising the r...
Read More >
Is it just me, or has JLo and Shakira’s halftime performance at the Super Bowl received more attent...
Read More >